San Francisco, CA, United States of America

Wendy Fantl

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 6.4

ph-index = 8

Forward Citations = 186(Granted Patents)


Location History:

  • Emeryville, CA (US) (2012 - 2013)
  • San Francisco, CA (US) (2006 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Inventor Wendy Fantl

Introduction: Wendy Fantl is a prominent inventor based in San Francisco, California, who has made significant strides in the field of medical research. With a remarkable portfolio of 15 patents, her groundbreaking work focuses on innovative methodologies for the prognosis and diagnosis of ovarian cancer, as well as various other diseases.

Latest Patents: Among Wendy Fantl's latest patents is a sophisticated method for prognosis and diagnosis of ovarian cancer, which discloses cellular markers indicating a poor prognosis for patients. This invention outlines the utilization of the frequency of specific cells expressing vimentin, cMyc, or HE4 within ovarian tumor tissue to forecast the likelihood of relapse in ovarian cancer patients. In addition, she has developed methods that facilitate the determination of activation states of multiple proteins in single cells. This innovative approach allows for rapid detection of heterogeneity within complex cell populations based on activation states and expression markers, enabling the identification of cellular subsets showing correlated changes. Her methods can be applied in analyzing diseases such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN).

Career Highlights: Wendy has built a remarkable career through her dedication to medical advancements. Her successful patent portfolio underscores her commitment to enhancing diagnostic and treatment methods, which have the potential to transform patient care.

Collaborations: Throughout her career, Wendy has collaborated with notable professionals such as Daniel J. Poon and David B. Rosen. She has been associated with reputable companies, including Nodality, Inc., and Novartis AG, where her expertise has contributed to furthering innovative medical research.

Conclusion: Wendy Fantl is a trailblazer in the realm of medical innovation, with patents that exemplify her dedication to improving cancer diagnostics and treatments. Her work not only enhances our understanding of ovarian cancer but also paves the way for advancements in other diseases, showcasing her invaluable contributions to modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…